Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JOHN W. who wrote (2262)	10/10/1997 12:10:00 AM
From: Joe E.	of 6136

John W. re your note about the Morgan Stanley analyst. Thanks for providing it. One part particularly caught my eye " In addition, according to the company's estimates, up to 15% of patients are taking two protease inhibitors in combination. This serves to increase the protease inhibitor market as a whole." If this is true they will certainly blow past the Morgan Stanley estimates for sales and earnings. P. S. Welcome back (again)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next